{
    "title": "Moderna reins in 2023 COVID vaccine forecast, shares tumble",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12701841/Moderna-tempers-2023-COVID-vaccine-sales-forecast.html",
    "date": "2023-11-02",
    "keywords": [
        "vaccine",
        "year",
        "loss",
        "revenue",
        "rsv",
        "company",
        "wingrove",
        "leo",
        "thursday",
        "forecast",
        "demand",
        "flu",
        "shot",
        "expectation",
        "covid19",
        "market",
        "share",
        "covid",
        "growth",
        "resizing",
        "end",
        "maker",
        "launch",
        "anticipation",
        "drop",
        "companys",
        "date",
        "stock",
        "low",
        "trade",
        "lone",
        "product",
        "td",
        "analyst",
        "tyler",
        "van",
        "buren",
        "research",
        "note",
        "iqvia",
        "spikevax",
        "brand",
        "name",
        "department",
        "health",
        "time",
        "campaign",
        "help",
        "cambridge",
        "massachusetts",
        "virus",
        "latestage",
        "trial",
        "average",
        "modernas",
        "combination",
        "covidflu",
        "officer",
        "jamey",
        "mock",
        "interview",
        "point",
        "top",
        "continue",
        "capacity",
        "tax",
        "reserve",
        "production",
        "contract",
        "manufacturer",
        "lonza",
        "future",
        "cost",
        "quarter",
        "reporting",
        "michael",
        "erman",
        "york",
        "bengaluru",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}